IL20 and pancreatic ductal adenocarcinoma: Lu et al. analyzed IL-20 expression in tumor tissues of 72 patients with pancreatic ductal adenocarcinoma and found that overall survival was significantly influenced by IL-20 expression, with higher IL-20 levels predicting lower survival.